Skip to content
Peptidepedia

Semax Stacking Guide: Best Combinations & Protocols (2026)

From Peptidepedia, the trusted peptide wiki.

Stacking

Semax's multifactorial mechanism of action makes it a logical candidate for combination with compounds that address complementary neurological pathways.

Semax + Selank

The most commonly discussed pairing. Semax provides dopaminergic activation, BDNF upregulation, and cognitive drive; Selank adds GABAergic modulation and anxiolysis. See Selank vs Semax for a detailed comparison of both peptides. Both are intranasal peptides with compatible administration routes and timing. The combination aims to enhance cognition and motivation while maintaining calm focus, stimulation without agitation. Both are approved medications in Russia, though no formal combination trials have been published.

Semax + Noopept

Noopept is a synthetic dipeptide nootropic that also enhances BDNF and NGF levels. The combination is popular in nootropic communities for synergistic neurotrophic stimulation. Mechanistically, the overlap in BDNF pathways raises theoretical concerns about excessive neurotrophin signaling, though no adverse interactions have been reported.

Semax + Racetams

Some users combine Semax with piracetam or other racetam-class nootropics. The rationale is that racetams modulate AMPA and acetylcholine receptor systems while Semax works through neurotrophin and monoamine pathways. These are non-overlapping mechanisms that could produce additive cognitive benefits.

General Stacking Caution: Formal interaction studies do not exist for any Semax combinations. Given Semax's effects on dopaminergic and serotonergic systems, particular caution is warranted when combining it with SSRIs, MAOIs, stimulants, or other serotonergic/dopaminergic drugs. Establishing individual response to Semax alone before adding compounds is essential.

Frequently Asked Questions

Both are Russian-developed intranasal peptides, but they derive from different parent molecules and target different primary outcomes. Semax is an ACTH(4-7) analog focused on cognitive enhancement, BDNF upregulation, and neuroprotection. Selank is a tuftsin analog that primarily modulates GABA and serotonin for anxiolytic effects. Some practitioners combine them for complementary cognitive and mood support.

This content is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.

References

  1. Dergunova LV, Filippenkov IB, Stavchansky VV, et al. Novel insights into the protective properties of ACTH(4-7)PGP (Semax) peptide at the transcriptome level following cerebral ischaemia-reperfusion in rats. Genes (Basel). 2020;11(6):681.
  2. Filippenkov IB, Stavchansky VV, Denisova AE, et al. Novel insights into the protective properties of ACTH(4-7)PGP (Semax) peptide at the transcriptome level following cerebral ischaemia-reperfusion in rats. BMC Neurosci. 2014;15:63.
  3. Shadrina MI, Dolotov OV, Grivennikov IA, et al. Comparison of the temporary dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action. J Mol Neurosci. 2010;41(1):30-35.
  4. Eremin KO, Kudrin VS, Saransaari P, Oja SS, Grivennikov IA, Myasoedov NF, Rayevsky KS. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochem Res. 2005;30(12):1493-1500.
  5. Kaplan AY, Kochetova AG, Nezavibathko VN, Rzhevskii DA, Roshchina IF, Ashmarin IP. Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome. Med Hypotheses. 2007;68(2):306-310.
  6. Gusev EI, Skvortsova VI, Chukanova EI. The efficacy of semax in the treatment of patients at different stages of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(3):61-68.
  7. Gavrilova SA, Golubev AI, Lipina TV, et al. Investigation of mechanisms of neuro-protective effect of semax in acute period of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 1999;99(5):15-19.
  8. Ioseliani TK, Kozaev GG, Poletaeva II, Elizarova IP. Semax in the treatment of glaucomatous optic neuropathy in patients with normalized ophthalmic tone. Vestn Oftalmol. 2001;117(4):5-8.
  9. Filippenkov IB, Remizova JA, Denisova AE, et al. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell Mol Neurobiol. 2024;44(1):71.
  10. Myasoedov NF, Andreyeva LA, Grigorjeva ME, et al. Development of peptide biopharmaceuticals in Russia. Pharmaceutics. 2022;14(4):716.
  11. Stavchansky VV, Dergunova LV, Filippenkov IB, et al. Brain protein expression profile confirms the protective effect of the ACTH(4-7)PGP peptide (Semax) in a rat model of cerebral ischemia-reperfusion. Int J Mol Sci. 2021;22(12):6179.
←Read the full Semax guide

“Peptidepedia compiles and maintains peptide information from peer-reviewed research, clinical trials, and verified laboratory data.”